Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD)

Overview


Plain-Language Overview

Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is a genetic condition that affects the kidneys, specifically the tubules and the surrounding tissue. It causes a gradual loss of kidney function over time, often leading to chronic kidney disease and eventually kidney failure. The disease is inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the condition if one parent is affected. People with ADTKD may experience symptoms like high blood pressure, reduced urine concentration, and sometimes gout due to elevated uric acid levels. The disease primarily impacts the kidney's ability to filter waste and maintain fluid and electrolyte balance.

Clinical Definition

Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is a hereditary disorder characterized by progressive tubulointerstitial fibrosis and tubular atrophy leading to chronic kidney disease. It is caused by mutations in genes such as UMOD, MUC1, REN, and HNF1B, which affect proteins involved in tubular function and structure. The disease manifests with slowly progressive renal insufficiency, bland urinary sediment, and minimal proteinuria. Patients often develop hyperuricemia and gout due to impaired uric acid excretion. Histologically, the kidneys show interstitial fibrosis and tubular atrophy without significant glomerular involvement. ADTKD is clinically significant as it leads to end-stage renal disease typically in adulthood, requiring dialysis or transplantation.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.